Kirk Taylor
Plus aucun poste en cours
Fortune : 18 620 $ au 30/04/2024
Profil
Kirk Taylor served as the Chief Medical Officer & Executive Vice President at Brainstorm Cell Therapeutics, Inc. in 2023 and as the Senior VP-Medical Affairs Strategy & Operations at Verastem, Inc. from 2018 to 2019.
He completed his undergraduate studies at Harvard University, his graduate studies at The University of California, San Francisco, and his doctorate at State University of New York at Downstate Medical Center.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 01/05/2023 | 35 000 ( 0,05% ) | 18 620 $ | 30/04/2024 |
Anciens postes connus de Kirk Taylor
| Sociétés | Poste | Fin |
|---|---|---|
| BRAINSTORM CELL THERAPEUTICS INC. | Directeur Technique/Scientifique/R&D | 18/10/2023 |
| VERASTEM, INC. | Corporate Officer/Principal | 01/08/2019 |
Formation de Kirk Taylor
| Harvard University | Undergraduate Degree |
| State University of New York at Downstate Medical Center | Doctorate Degree |
| The University of California, San Francisco | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| VERASTEM, INC. | Health Technology |
| BRAINSTORM CELL THERAPEUTICS INC. | Health Technology |